Emirena Garrafa

1.8k total citations
34 papers, 669 citations indexed

About

Emirena Garrafa is a scholar working on Oncology, Molecular Biology and Epidemiology. According to data from OpenAlex, Emirena Garrafa has authored 34 papers receiving a total of 669 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Oncology, 8 papers in Molecular Biology and 8 papers in Epidemiology. Recurrent topics in Emirena Garrafa's work include COVID-19 Clinical Research Studies (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Lymphatic System and Diseases (4 papers). Emirena Garrafa is often cited by papers focused on COVID-19 Clinical Research Studies (5 papers), Angiogenesis and VEGF in Cancer (5 papers) and Lymphatic System and Diseases (4 papers). Emirena Garrafa collaborates with scholars based in Italy, United States and Sweden. Emirena Garrafa's co-authors include Arnaldo Caruso, Giulio Alessandri, Francesca Spinella, Anna Bagnato, Laura Rosanò, Valeriana Di Castro, Rosella Levaggi, Ciro Paolillo, Raffaele Miniaci and Dario Di Luca and has published in prestigious journals such as Proceedings of the National Academy of Sciences, SHILAP Revista de lepidopterología and Cancer Research.

In The Last Decade

Emirena Garrafa

31 papers receiving 652 citations

Peers

Countries citing papers authored by Emirena Garrafa

Since Specialization

Citations

This map shows the geographic impact of Emirena Garrafa's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Emirena Garrafa with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Emirena Garrafa more than expected).

Fields of papers citing papers by Emirena Garrafa

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Emirena Garrafa. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Emirena Garrafa. The network helps show where Emirena Garrafa may publish in the future.

Co-authorship network of co-authors of Emirena Garrafa

This figure shows the co-authorship network connecting the top 25 collaborators of Emirena Garrafa. A scholar is included among the top collaborators of Emirena Garrafa based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Emirena Garrafa. Emirena Garrafa is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Dietary supplementation with a designer metabolic modulator improves MASLD and associated anxiety in mice 2025 ·Frontiers in Pharmacology ·(unknown), Gaia Favero, Emanuela Bottani, (unknown), Emirena Garrafa, Edoardo Parrella, Chiara Ruocco, Maurizio Ragni, Rita Rezzani, Enzo Nisoli, Alessandra Valerio	0
2	Multicenter study to improve clinical interpretation of anticardiolipin and anti-β2-glycoprotein I antibody test results for diagnosis of antiphospholipid syndrome 2025 ·Journal of Thrombosis and Haemostasis ·Lieve Van Hoovels, Silvia Piantoni, Els Bailleul, Sofie Schouwers, Massimo Radin, María Infantino, Emirena Garrafa, (unknown), (unknown), Stefanie Van den Bremt, Bert Vander Cruyssen, Katrien Devreese, Anǵela Tincani, Savino Sciascia, Xavier Bossuyt	0
3	A Mediterranean Diet-Oriented Intervention Rescues Impaired Blood Cell Bioenergetics in Patients with Metabolic Dysfunction-Associated Steatotic Liver Disease 2024 ·Diagnostics ·(unknown), Marika Vezzoli, (unknown), Emirena Garrafa, Bárbara Zanini, Emanuela Bottani, (unknown), Silvia Marconi, Chiara Ricci, Alessandra Valerio	3
4	Sustained post-rituximab B-cell depletion is common in ANCA-associated vasculitis and is affected by sex and renal function 2023 ·Nephrology Dialysis Transplantation ·Federica Mescia, Chiara Salviani, M. Tonoli, Stefania Affatato, Daniele Moratto, (unknown), Alice Guerini, (unknown), (unknown), Elisa Delbarba, Roberto Zubani, Emirena Garrafa, Marco Chiarini, Gina Gregorini, Francesco Scolari, Federico Alberici	7
5	Human iPSC-Derived 3D Hepatic Organoids in a Miniaturized Dynamic Culture System 2023 ·Biomedicines ·(unknown), (unknown), (unknown), Annamaria Fra, Emirena Garrafa, Manuela Cominelli, Rosanna Verardi, Pietro Luigi Poliani, Silvia Dotti, Riccardo Villa, Giovanna Mazzoleni, Patrizia Dell’Era, Nathalie Steimberg	4
6	Mitochondrial Dysfunction in Peripheral Blood Mononuclear Cells as Novel Diagnostic Tools for Non-Alcoholic Fatty Liver Disease: Visualizing Relationships with Known and Potential Disease Biomarkers 2023 ·Diagnostics ·Emirena Garrafa, (unknown), Marika Vezzoli, Emanuela Bottani, Bárbara Zanini, (unknown), Renata Bracale, Chiara Ricci, Alessandra Valerio	8
7	Predictive markers for clinical outcomes in a cohort of diabetic patients hospitalized for COVID-19 2022 ·Diabetology & Metabolic Syndrome ·Sara Madaschi, Eugenia Resmini, (unknown), Giulia Massari, Paola Gamba, Marco Sandri, Stefano Calza, (unknown), Emanuela Zarra, Silvia Dotti, (unknown), Barbara Agosti, Emirena Garrafa, Angela Girelli	4
8	Low-dose Lung Radiotherapy for COVID-19-related Pneumonia: Preliminary Results of the Italian Mono-institutional COLOR-19 Trial 2022 ·In Vivo ·Stefano Maria Magrini, Davide Tomasini, Emanuele Focà, Emirena Garrafa, (unknown), Andrea Emanuele Guerini, Luca Triggiani, Roberto Bresciani, (unknown), (unknown), (unknown), (unknown), (unknown), Roberto Maroldi, Michela Buglione, Luigi Spiazzi	2
9	Plasma Cystatin C Correlates with Plasma NfL Levels and Predicts Disease Progression in Parkinson’s Disease 2021 ·Neurodegenerative Diseases ·Alberto Imarisio, Andrea Pilotto, Emirena Garrafa, F. L. Conforti, Stefano Masciocchi, Rosanna Turrone, Stefano Gipponi, Elisabetta Cottini, Maria Cristina Rizzetti, Vanessa Porrini, Cristina Gussago, (unknown), Fiorella Guadagni, Henrik Zetterberg, Nicholas J. Ashton, Abdul Hye, Alessandro Padovani	6
10	Adherence and Optimization of Angiotensin Converting Enzyme Inhibitor/Angiotensin II Receptors Blockers and Beta-Blockers in Patients Hospitalized for Acute Heart Failure 2021 ·ESC Heart Failure ·Valentina Carubelli, Carlo Lombardi, Claudia Specchia, Giulia Peveri, Chiara Oriecuia, Daniela Tomasoni, Mattia Di Pasquale, Riccardo M. Inciardi, Emirena Garrafa, Marco Metra	14
11	Early prediction of in-hospital death of COVID-19 patients: a machine-learning model based on age, blood analyses, and chest x-ray score 2021 ·eLife ·Emirena Garrafa, Marika Vezzoli, Marco Ravanelli, Davide Farina, Andrea Borghesi, Stefano Calza, Roberto Maroldi	22
12	Plasmacytoid Dendritic Cells Depletion and Elevation of IFN-γ Dependent Chemokines CXCL9 and CXCL10 in Children With Multisystem Inflammatory Syndrome 2021 ·Frontiers in Immunology ·(unknown), Mauro Giacomelli, Emirena Garrafa, Nicola Tamassia, (unknown), Piercarlo Poli, Silviana Timpano, Giulia Baresi, Fiammetta Zunica, Marco Cattalini, Daniele Moratto, Marco Chiarini, Elvira Stefania Cannizzo, Giulia Marchetti, Marco A. Cassatella, Andrea Taddio, Alberto Tommasini, Raffaele Badolato	37
13	Respiratory function, autonomic dysfunction, and systemic inflammation are closely linked in patients with COPD and tidal flow limitation: An exploratory study 2020 ·Respiratory Physiology & Neurobiology ·Claudio Tantucci, Damiano Bottone, Guido Levi, (unknown), Nicola Venturoli, (unknown), Emirena Garrafa, Laura Pini	5
14	When fear backfires: Emergency department accesses during the Covid-19 pandemic 2020 ·Health Policy ·Emirena Garrafa, Rosella Levaggi, Raffaele Miniaci, Ciro Paolillo	42
15	Laboratory Considerations Amidst the Coronavirus Disease 2019 Outbreak: The Spedali Civili in Brescia Experience 2020 ·Bioanalysis ·Emirena Garrafa, Duilio Brugnoni, (unknown), Laura Andréoli, Emanuele Focà, Massimo Salvetti, Francesco Castelli, Franco Franceschini, Simone Piva, María Lorenza Muiesan, Nicola Latronico, Rosella Levaggi	7
16	Beyond Chronological Age: Frailty and Multimorbidity Predict In-Hospital Mortality in Patients With Coronavirus Disease 2019 2020 ·The Journals of Gerontology Series A ·Alessandra Marengoni, Alberto Zucchelli, Davide Liborio Vetrano, Andrea Armellini, Emanuele Botteri, Franco Nicosia, Giuseppe Romanelli, (unknown), (unknown), Emirena Garrafa, Luigi Ferrucci, Laura Fratiglioni, Roberto Bernabei, Graziano Onder	71
17	A Simple Blood Test, Such as Complete Blood Count, Can Predict Calcification Grade of Abdominal Aortic Aneurysm 2017 ·International Journal of Vascular Medicine ·Marika Vezzoli, Stefano Bonardelli, (unknown), Marco Ravanelli, Emirena Garrafa	3
18	Endothelin-1 cooperates with hypoxia to induce vascular-like structures through vascular endothelial growth factor-C, -D and -A in lymphatic endothelial cells 2012 ·Life Sciences ·Emirena Garrafa, Valentina Caprara, Valeriana Di Castro, Laura Rosanò, Anna Bagnato, Francesca Spinella	14
19	Endothelin-1 Stimulates Lymphatic Endothelial Cells and Lymphatic Vessels to Grow and Invade 2009 ·Cancer Research ·Francesca Spinella, Emirena Garrafa, Valeriana Di Castro, Laura Rosanò, Maria Rita Nicotra, Arnaldo Caruso, Pier Giorgio Natali, Anna Bagnato	78
20	Transforming Growth Factor-β1 and CD105 Promote the Migration of Hepatocellular Carcinoma–Derived Endothelium 2008 ·Cancer Research ·Anna Benetti, Angiola Berenzi, Marco Gambarotti, Emirena Garrafa, Maurizio Gelati, Enrico Dessy, Nazario Portolani, Tullio Piardi, Stefano Maria Giulini, Arnaldo Caruso, Gloria Invernici, Eugenio Parati, Roberto F. Nicosia, Giulio Alessandri	66

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact